 |
December 03, 2017, 07:05:43 AM |
|
DNA is a winner. The reason why its under the radar, is because the team has been hard working on their project and not on marketing/promoting. This is a good thing!
This token changes the way genomic data will be shared around the world. This is a $20b industry, expected to double in the next 10 years. Researchers take value from bigger datasets, and Encrypgen will connect labs around the world with their tech.
Imagine you're a researcher interested in developing a drug on glaucoma. You would have to design a way of recruiting people to come to your lab, give their genomic data and then start analysing it. It's expensive, slow, and you only get the local people.
With the DNA token you could just go online, search, and download all the metadata of people with glaucoma anywhere in the world, instantly.
This isn't a pipedream, you can start buying genetic data on their system by Christmas. And the market cap is only $4m. The extremely low market cap makes EncryGen (DNA) very undervalued and a an attractive investment opportunity now.
25 Million tokens have been burned for new max supply of 75 Million, CMC has not been updated. They say they will burn another "smaller" amount, I'll estimate that to be 10 million.
That leaves us with 35 M / 65 M circ/supply
>Website updated and launched today
>Spero Research report released soon (Last coin that had a paper on it went 3x)
>Product being launched in 3 weeks
>Further announcements coming
>Paying customers
>Exchanges are being applied to
As always, DYOR. But DNA has major upside potential and many Green Arrows ahead!
|
